Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
See Latest ArticlesWhat is new in methotrexate for psoriasis
Dermatology in Practice, 07/06/09
Psoriasis is a chronic, immune-mediated inflammatory skin disease that affects approximately 2–3% of the world’s population. For many patients, it is a lifelong condition; 20–30% of patients will have severe psoriasis and will often require systemic therapy to achieve disease control. Methotrexate was first introduced as a treatment for psoriasis over 50 years ago and, in spite of the development of many new biological treatments, it remains the gold standard systemic therapy for psoriasis in Europe.
Related Articles
Pediatric psoriasis: an update
Therapeutics and Clinical Risk Management, 10/22/09
Relevance Score: 95%
FDA Approves New Drug to Treat Psoriasis
Internet Source, 11/02/09
Relevance Score: 91%
Study shows major burden of psoriasis
Internet Source, 10/29/09
Relevance Score: 91%
Prevalence of myocardial infarction in patients with psoriasis in central China
Journal of the European Academy of Dermatology and Venereology, 10/27/09
Relevance Score: 91%
Why nail psoriasis remains difficult to treat
Dermatology in Practice, 10/12/09
Relevance Score: 91%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinically relevant drug interactions of current antifungal agents
Mycoses, 12/15/09
Treatment of head lice with dimeticone 4% lotion: comparison of two formulations in a randomised controlled trial in rural Turkey
BMC Public Health, 12/15/09
Pharmacotherapy of regional melanoma therapy
Expert Opinion in Pharmacotherapy, 12/14/09
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Analysis of psoriatic patients registered in Asahikawa Medical College Hospital from 1983 to 2007
Journal of Dermatology, 12/08/09
Modulation of extracellular matrix through keratinocyte-fibroblast crosstalk
Expert Review of Dermatology, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor